[1-(Hydroxymethyl)cyclopropyl]acetonitrile, 94.0%, 100g

2-Methoxy-5-(trifluoromethyl)benzamide, 10g

Sodium 4-fluorobenzoate, 97.0%, 500g

N-(azetidin-3-yl)-1-methyl-1H-pyrazol-4-amine dihydrochloride, 95.0%, 250mg

3-Bromo-4-chlorobenzonitrile, 98.0%, 5g

2-(morpholin-4-ylmethyl)aniline sulfate hydrate, 95.0%, 10g

2-HYDROXY-N-METHOXY-N-METHYL-[1,1'-BIPHENYL]-3-CARBOXAMIDE, 95.0%, 250mg

(3-Bromopyridin-4-yl)methanamine dihydrochloride, 97%, 1g

EDC-HCI, PEPTIPURE®, min. 99%, 25 g, glass packaging

1-tert-Butyl 2-methyl piperazine-1,2-dicarboxylate hydrochloride, 95.0%, 1g

Microliter syringe GASTIGHT® series 1700 Point type 3, 50 µl, 1705 RNR, 1 piece

(S)-3-Amino-3-(3-(trifluoromethyl)phenyl)propanoic acid hydrochloride, 95%, 1g

1-(2-fluorophenyl)-2,2-dimethylcyclopropanecarboxylic acid, 95.0%, 10g